{"transactions":[{"id":2409763,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":130750,"kind":"organization","name":"InCube Labs, L.L.C.","position":1,"cik":"0001873082","reported_name":"InCube Labs, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-02-08T02:36:59.000Z","date":"2022-02-03","kind":"other","acquired":true,"shares":13923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received in kind pro rata distribution from Biologix Partners, LP (3,181 shares of Class A Common Stock) and VH Rani, LP. (10,742 shares of Class A Common Stock), to its limited partners."}],"balance_after":13923,"source":{"system":"sec-edgar","filing":"0001209191-22-007636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000120919122007636/doc4.xml","form_type":"4"}}]}